Shares of Spanish company Inditex (ITX.ES), responsible for brands such as Zara, Bershka, Massimo Dutti and Pull&Bear, among others, are gaining more than 5.5% today following the release of strong results for the first part of the year.
What pleases investors in particular is the company's strong performance in both a tough period in seasonal terms and an uncertain global economic situation. The company's results indicate that, despite circular pressures, the company's core brand collections have found their audience. Inditex intends to spend €2.7 billion this year to implement new technologies across the company and expand its logistics capacity, which will include increased throughput for Zara, Bershka and footwear brands.
Still, Inditex warned that currency changes, mainly a weaker dollar, will reduce revenues by 3% in 2024, more than originally forecast.
FIRST-QUARTER RESULTS
- Ebit €3.54 billion, +12% y/y, estimated €3.48 billion
- Ebit margin 19.6% vs. 18.8% y/y, estimated 19.4%
- Net sales €18.07 billion, +7.2% y/y, estimated €18.02 billion
- Zara & Zara Home sales €13.03 billion, +5.4% y/y
- Pull&Bear sales €1.12 billion, +7.9% y/y
- Massimo Dutti sales €904 million, +7.4% y/y
- Bershka sales €1.38 billion, +17% y/y
- Stradivarius sales €1.26 billion, +17% y/y
- Oysho sales 368 million euros, +6.4% y/y
- Gross profit €10.54 billion, +7.6% y/y, estimated €10.51 billion
- Gross margin 58.3% vs. 58.2% y/y, estimated 58.4%
- Ebitda €5.04 billion, +8.1% y/y, estimated €5.02 billion
- Ebitda margin 27.9% vs. 27.7% y/y, estimated 27.9%
- Net profit €2.77 billion, +10% y/y, estimated €2.78 billion
- EPS €0.889 vs. €0.807 y/y, estimated €0.89
Inditex is up more than 5% today, holding on to a dynamic upward trend that has been maintained since 2022. Source: xStation
DE40: Decline of sentiment in Europe
Atlassian beats revenue and earnings forecasts in Q1 2026
Economic calendar: Macroeconomics and Fed Officials’ Speeches in Focus (31.10.2025)
Morning wrap (31.10.2025)
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
